Why Drug Companies Are Rushing to Market Ketamine Medicines
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
Original Source
Read the full article at Nytimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.